| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Maini RN | |
| Williams RO | |||
| Feldmann M | |||
| P2860 | cites work | Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis | Q24564656 |
| Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis | Q28239197 | ||
| A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate | Q28295474 | ||
| The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 | ||
| Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data | Q30560117 | ||
| Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis | Q33557750 | ||
| Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies | Q33567277 | ||
| Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis | Q35132863 | ||
| Autoimmunity to type II collagen an experimental model of arthritis | Q36335891 | ||
| Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4 | Q36350833 | ||
| Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts | Q36351406 | ||
| Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors | Q36351673 | ||
| Induction of arthritis in monkeys by immunization with type II collagen | Q36355205 | ||
| Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice | Q37147228 | ||
| Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis | Q37253521 | ||
| Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint | Q37408069 | ||
| Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor | Q37558444 | ||
| Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity | Q38666665 | ||
| The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis | Q39475952 | ||
| Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment | Q39486764 | ||
| Predominantly T-Cell Infiltrate in Rheumatoid Synovial Membranes | Q39944481 | ||
| Collagen arthritis as a relevant model for rheumatoid arthritis | Q40338367 | ||
| Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG | Q40699364 | ||
| Biologic agents for treating rheumatoid arthritis. Concepts and progress | Q41398093 | ||
| Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis | Q44064388 | ||
| Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. | Q52221782 | ||
| Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. | Q54729757 | ||
| Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. | Q54784059 | ||
| Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α | Q56813295 | ||
| Homologous type II collagen induces chronic and progressive arthritis in mice | Q57352747 | ||
| Immunisation against heterologous type II collagen induces arthritis in mice | Q59053172 | ||
| Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage | Q59063497 | ||
| Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo | Q59082223 | ||
| CD4 monoclonal antibody pairs for immunosuppression and tolerance induction | Q61651783 | ||
| The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis | Q67567811 | ||
| Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor | Q67869949 | ||
| Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha | Q68007091 | ||
| Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis | Q68028260 | ||
| Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor | Q68827373 | ||
| Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis | Q70561942 | ||
| Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis | Q71010017 | ||
| Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra | Q71098362 | ||
| Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice | Q71555684 | ||
| Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice | Q71603105 | ||
| The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice | Q71889641 | ||
| The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis | Q72065831 | ||
| Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4 | Q72238634 | ||
| Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis | Q72526685 | ||
| Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice | Q72620618 | ||
| Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response | Q72692349 | ||
| Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA) | Q73149273 | ||
| Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein | Q73502940 | ||
| A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis | Q73574469 | ||
| DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition | Q73705668 | ||
| Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis | Q77403524 | ||
| Rodent models of arthritis: relevance for human disease | Q77650347 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cartilage | Q502730 |
| TNF | Q18032037 | ||
| P304 | page(s) | i75-80 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha | |
| P478 | volume | 59 Suppl 1 |
| Q38274571 | Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis |
| Q47252649 | Effects of sesamin on primary human synovial fibroblasts and SW982 cell line induced by tumor necrosis factor-alpha as a synovitis-like model |
| Q35804433 | Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation |
| Q26738338 | Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis |
| Q34786085 | Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis |
| Q34360546 | Immunotherapy for rheumatoid arthritis |
| Q28202653 | Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis |
| Q34587358 | Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis |
| Q35083869 | Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis |
| Q51716595 | Low Dietary c9t11-Conjugated Linoleic Acid Intake from Dairy Fat or Supplements Reduces Inflammation in Collagen-Induced Arthritis. |
| Q33648802 | MMP-3 and MMP-8 single-nucleotide polymorphisms are related to alcohol-induced osteonecrosis of the femoral head in Chinese males |
| Q24536131 | Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice |
| Q47776871 | Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice |
| Q35555622 | Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum |
| Q36633235 | Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis |
| Q39389959 | Targeted etanercept for treatment-refractory pain due to bone metastasis: Two case reports |
| Q36875765 | The remission of rheumatoid arthritis during pregnancy |
| Q86340489 | Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis |
| Q53945794 | Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. |
Search more.